Pathologica 4-07.pdf - Pacini Editore
Pathologica 4-07.pdf - Pacini Editore
Pathologica 4-07.pdf - Pacini Editore
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SLIDE SEMINAR JUNIORES<br />
Urothelial dysplasia. The thickness of the urothelium is usually<br />
normal four to seven layers but may be increased or decreased.<br />
There is loss of clearing of cytoplasm, nucleomegaly,<br />
irregularity of nuclear contours and altered chromatin distribution.<br />
Nucleoli are usually not conspicuous; only a minor degree<br />
of pleomorphism is allowable in dysplasia and the mitotic<br />
activity is variable though usually not in the higher layers.<br />
Loss of polarity is evidenced by crowding and nuclei with the<br />
long axis parallel to the basement membrane 16 . Comparison<br />
with more normal appearing urothelium, if present, may help<br />
in assessing features like nucleomegaly, and loss of clearing<br />
and polarity. The distinction between urothelial dysplasia and<br />
carcinoma in situ is essentially one of morphologic threshold<br />
since nuclear atypia is evident but should not be severe<br />
enough to merit a diagnosis of carcinoma in situ. The lamina<br />
propria is usually unaltered but may contain increased inflammation<br />
and/or neovascularity.<br />
Immunohistochemistry shows abnormal expression of CK20,<br />
Ki-67 and p53 in the majority of the cases, together or individually,<br />
and helps to distinguish reactive atypia from dysplasia<br />
but not dysplasia from CIS 5 . Increased reactivity for<br />
CD44 in all layers of the urothelium is, on the contrary, more<br />
commonly seen in reactive atypia 7 .<br />
Dysplastic lesions are typically seen in bladders with urothelial<br />
neoplasia and are uncommon in patients without it 17 . In<br />
patients with bladder tumors, the presence of dysplasia<br />
places them at higher risk for recurrence and progression 18 .<br />
Urothelial carcinoma in situ. Carcinoma in situ CIS Highgrade<br />
Intraurothelial Neoplasia is histologically characterized<br />
by unequivocal severe cytological atypia, i.e., the type<br />
of atypia usually seen in invasive urothelial carcinoma. The<br />
urothelium may be diminished in thickness or of normal<br />
thickness, while the observation of an increased thickness is<br />
exceedingly rare. Cells have large, irregular, hyperchromatic<br />
nuclei often with one or more large nucleoli. There is alteration<br />
or complete loss of polarity and mitotic activity is<br />
frequently observed 9 2 . The lamina propria is frequently hypervascular<br />
and inflamed reflecting the erythematous appearance<br />
witnessed on cystoscopy. When evaluating the degree<br />
of cytological atypia, it is always important the comparison<br />
with the cells of the surrounding normal urothelium.<br />
CIS may grow in the surrounding normal urothelium as clusters<br />
or isolated single cells pagetoid spread or undermining<br />
or overriding it 19 . The term of clinging CIS is used for cases<br />
where only a few residual cancer cells remain on the surface<br />
9 .<br />
A common feature of CIS is the lack of intercellular cohesion<br />
resulting in extensive denudation. Since denudation may occur<br />
also in association with trauma due to instrumentation or<br />
therapy, deeper sections through the paraffin block may be<br />
helpful in revealing atypical cells diagnostic for CIS. In the<br />
absence of atypical cells, the finding of extensive denudation,<br />
particularly when associated with neovascularity and chronic<br />
inflammation in the lamina propria, must be included in<br />
the report and correlation with urine cytology findings may<br />
be suggested 1 .<br />
Potential mimics of CIS are the truncated papillae that remain<br />
after treatment of papillary carcinoma with Mitomycin<br />
C and thiotepa, particularly when associated with denudation<br />
and inflammation 20 . CIS can be mimicked 21 by infection of<br />
immunocompromised patients with the human polyoma virus<br />
resulting in large homogeneous inclusions in enlarged nuclei<br />
of urothelial cells.<br />
The differentiation of CIS from other flat urothelial lesions<br />
with atypia is based primarily on the cytologic features. Lim-<br />
99<br />
ited studies suggest a potential adjunctive role of immunohistochemistry<br />
7 22-24 . CIS frequently shows diffuse, strong cytoplasmic<br />
reactivity for CK20 and diffuse nuclear reactivity<br />
for p53 throughout the full thickness of the urothelium.<br />
CD44 reactivity is limited to a residual basal cell layer of<br />
normal urothelium when present, but is absent in the neoplastic<br />
cells. A panel consisting of these three antibodies is<br />
important as not all cases of CIS consistently exhibit the<br />
characteristic immunostaining.<br />
CIS with microinvasion. In bladder carcinoma in situ, a<br />
careful search should be made for the presence of invasion.<br />
Microinvasive carcinoma of the urinary bladder is defined by<br />
invasion into the lamina propria to a depth ranging 2-to-5<br />
mm from the basement membrane 25 26 . Microinvasion appears<br />
as direct extension cords tentacular, single cells, or single<br />
cells and clusters of cells. The neoplastic cells may be interspersed<br />
among and masked by chronic inflammation. In<br />
this case immunohistochemistry with antibodies against CEA<br />
or cytokeratins such as AE1-AE3 should be applied to identify<br />
the invading cells 9 . Desmoplasia or retraction artifacts<br />
that may mimic vascular invasion are useful in recognizing<br />
invasion 27 28 .<br />
Some patients who have had prior bladder biopsies or<br />
transurethral resections undergo a repeat resection within<br />
several months for various reasons. The detection of a few<br />
residual tumour cells in bladder specimens with prior biopsy<br />
site changes can be challenging based on histology alone.<br />
Immunohistochemistry for cytokeratins may be used as an<br />
adjunct in this situation. However, when interpreting CK<br />
stains for the detection of residual tumour cells, one should<br />
pay attention to the nature of the cells and not assume all CK<br />
positive cells are neoplastic 2 .<br />
Papillary urothelial neoplasms. The papillary lesions are<br />
here described according to the WHO 2004 classification 1 .<br />
We do not report here the WHO 1973 classification because<br />
it is already well known in the pathology, urology and oncology<br />
communities. There still is debate as to whether the<br />
WHO 2004 system should be the only one to be used and<br />
whether the WHO 1973 system should be abandoned. Current<br />
practice in patient’s management is still based on the old<br />
one.<br />
Urothelial papilloma. Urothelial papilloma without qualifiers<br />
refers to the exophytic variant of papilloma, defined as<br />
a discrete papillary growth with a central fibrovascular core<br />
lined by urothelium of normal thickness and cytology. This is<br />
a rare, benign condition typically occurring as a small, isolated<br />
growth, commonly but not exclusively seen in younger<br />
patients 29 30 .<br />
Inverted urothelial papilloma. Although not strictly speaking<br />
a papillary lesion is classified here because it shares certain<br />
features with exophytic urothelial papilloma. The histology<br />
of inverted papillomas has been well described 31 . Rarely,<br />
cases are hybrid in which significant portions of the lesion resemble<br />
exophytic urothelial papillomas and inverted urothelial<br />
papillomas. These lesions should be classified as papillomas<br />
with both exophytic and inverted features 2 .<br />
When completely excised, inverted papillomas have a very<br />
low risk of recurrence. In a minority of cases, they may be<br />
associated with urothelial carcinoma occurring either concurrently<br />
or subsequently. Rarely, cases of urothelial carcinoma<br />
arising in inverted urothelial papillomas have been described<br />
1 .<br />
Papillary urothelial neoplasm of low malignant potential.<br />
A papillary urothelial lesion with an orderly arrangement of<br />
cells with minimal architectural abnormalities and minimal